+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Leukemia Drugs Market Research Reports

Bendamustine (CAS 16506-27-7) Global Market Research Report 2024 - Product Thumbnail Image

Bendamustine (CAS 16506-27-7) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Clofarabine (CAS 123318-82-1) Global Market Research Report 2024 - Product Thumbnail Image

Clofarabine (CAS 123318-82-1) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
6-Thioguanine (CAS 154-42-7) Global Market Research Report 2024 - Product Thumbnail Image

6-Thioguanine (CAS 154-42-7) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
CD40 Agonists & CD40/L Antagonists Pipeline Review - Product Thumbnail Image

CD40 Agonists & CD40/L Antagonists Pipeline Review

  • Report
  • November 2024
  • Global
From
Global Leukemia Antibodies Market, Drug Sales & Clinical Trials Insight 2028 - Product Thumbnail Image

Global Leukemia Antibodies Market, Drug Sales & Clinical Trials Insight 2028

  • Report
  • May 2022
  • 330 Pages
  • Global
From
Ayvakit Patent, Sales & Clinical Trials Insight 2028 - Product Thumbnail Image

Ayvakit Patent, Sales & Clinical Trials Insight 2028

  • Report
  • October 2021
  • 85 Pages
  • Global
From
Global Acute Myeloid Leukemia (AML) Treatment Market: Forecast and Trends - Product Thumbnail Image

Global Acute Myeloid Leukemia (AML) Treatment Market: Forecast and Trends

  • Report
  • August 2023
  • 122 Pages
  • Global
From
Leukemia Therapeutics Market by Type (CLL, ALL, CML, AML), Treatment Type (Chemotherapy & Targeted Drugs), Mode of Administration (Oral, Injectable), Molecule Type (Small Molecules, Biologics), Gender, and Region - Global Forecast to 2024 - Product Thumbnail Image

Leukemia Therapeutics Market by Type (CLL, ALL, CML, AML), Treatment Type (Chemotherapy & Targeted Drugs), Mode of Administration (Oral, Injectable), Molecule Type (Small Molecules, Biologics), Gender, and Region - Global Forecast to 2024

  • Report
  • May 2019
  • 126 Pages
  • Global
From
FLT3 Inhibitors Market - A Global and Country Analysis: Focus on Commercialized Therapy, Potential Pipeline Product, and Region - Analysis and Forecast, 2022-2032 - Product Thumbnail Image

FLT3 Inhibitors Market - A Global and Country Analysis: Focus on Commercialized Therapy, Potential Pipeline Product, and Region - Analysis and Forecast, 2022-2032

  • Report
  • August 2022
  • 152 Pages
  • Global
From
Hemato Oncology Testing Market by Product & Services (Services, Assay Kits), Cancer (Leukemia (Acute Myeloid, Acute Lymphocytic), Lymphoma (Non-Hodgkin, Hodgkin), Technology (PCR, NGS), End User - Global Forecast to 2027 - Product Thumbnail Image

Hemato Oncology Testing Market by Product & Services (Services, Assay Kits), Cancer (Leukemia (Acute Myeloid, Acute Lymphocytic), Lymphoma (Non-Hodgkin, Hodgkin), Technology (PCR, NGS), End User - Global Forecast to 2027

  • Report
  • November 2022
  • 141 Pages
  • Global
From
US Acute Myeloid Leukemia Market to 2028 - Product Thumbnail Image

US Acute Myeloid Leukemia Market to 2028

  • Report
  • October 2023
  • 85 Pages
  • United States
From
Cancer/Tumor Profiling Market by Biomarker Type (Genetic, Protein) Technology (NGS, PCR, ISH, IHC) Cancer Type (Breast, Lung, Colorectal, Prostate, Leukemia) Application (Clinical, Research) End User (Pharma, Academic, CRO) - Global Forecast to 2030 - Product Thumbnail Image

Cancer/Tumor Profiling Market by Biomarker Type (Genetic, Protein) Technology (NGS, PCR, ISH, IHC) Cancer Type (Breast, Lung, Colorectal, Prostate, Leukemia) Application (Clinical, Research) End User (Pharma, Academic, CRO) - Global Forecast to 2030

  • Report
  • September 2023
  • 270 Pages
  • Global
From
Market Spotlight: Myelodysplastic Syndrome (MDS) - Product Thumbnail Image

Market Spotlight: Myelodysplastic Syndrome (MDS)

  • Report
  • February 2021
  • 60 Pages
  • Global
Venclexta - Product Thumbnail Image

Venclexta

  • Report
  • January 2019
  • 45 Pages
  • Global
From
Treanda/Bendeka - Product Thumbnail Image

Treanda/Bendeka

  • Report
  • January 2019
  • 58 Pages
  • Global
From
Kymriah - Product Thumbnail Image

Kymriah

  • Report
  • January 2019
  • 38 Pages
  • Global
From
Imbruvica - Product Thumbnail Image

Imbruvica

  • Report
  • January 2019
  • 51 Pages
  • Global
From
Gazyva - Product Thumbnail Image

Gazyva

  • Report
  • January 2019
  • 40 Pages
  • Global
From
Arzerra - Product Thumbnail Image

Arzerra

  • Report
  • January 2019
  • 18 Pages
  • Global
From
Pomalyst - Product Thumbnail Image

Pomalyst

  • Report
  • August 2018
  • 21 Pages
  • Global
From
Loading Indicator

The Leukemia Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat leukemia, a type of cancer of the blood and bone marrow. These drugs are used to reduce the number of cancer cells in the body, and to prevent the spread of the disease. Commonly used drugs include chemotherapy, targeted therapy, and immunotherapy. Chemotherapy is a type of drug that works by killing cancer cells. Targeted therapy is a type of drug that works by targeting specific molecules in cancer cells, and immunotherapy is a type of drug that works by stimulating the body's immune system to fight cancer cells. The Leukemia Drugs market is highly competitive, with many companies competing for market share. Some of the major players in the market include Novartis, Pfizer, Bristol-Myers Squibb, Celgene, and Amgen. Show Less Read more